| MeSH term | MeSH ID | Detail |
|---|---|---|
| Severe Combined Immunodeficiency | D016511 | 1 associated lipids |
| Peri-Implantitis | D057873 | 1 associated lipids |
| Adrenocortical Adenoma | D018246 | 1 associated lipids |
| Hyperparathyroidism, Primary | D049950 | 1 associated lipids |
| Breast Neoplasms, Male | D018567 | 1 associated lipids |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | D054438 | 1 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Legg-Calve-Perthes Disease | D007873 | 1 associated lipids |
| Fluorosis, Dental | D009050 | 1 associated lipids |
| Bone Demineralization, Pathologic | D018488 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rubin J et al. | IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12213884 |
| Palmqvist P et al. | IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. | 2002 | J. Immunol. | pmid:12218157 |
| Sandor M et al. | A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. | 2002 | Biomaterials | pmid:12219832 |
| Shiotani A et al. | Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. | 2002 | Anat. Rec. | pmid:12221720 |
| Kudo O et al. | Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. | 2002 | J. Pathol. | pmid:12237882 |
| Hofbauer LC et al. | High bone density due to a mutation in LDL-receptor-related protein 5. | 2002 | N. Engl. J. Med. | pmid:12240686 |
| Williamson E et al. | Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. | 2002 | J. Immunol. | pmid:12244151 |
| Ferrer Cañabate J et al. | [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. | 2002 | An Med Interna | pmid:12244784 |
| Kazama JJ et al. | Circulating osteoprotegerin is not removed through haemodialysis membrane. | 2002 | Nephrol. Dial. Transplant. | pmid:12271009 |
| Lee SW et al. | TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. | 2002 | J. Biochem. Mol. Biol. | pmid:12296995 |
| Standal T et al. | Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. | 2002 | Blood | pmid:12351414 |
| pmid:12354528 | ||||
| Yang SY et al. | Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. | 2002 | Arthritis Rheum. | pmid:12355500 |
| Palenzuela L et al. | Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. | 2002 | J. Med. Genet. | pmid:12362049 |
| Fu Q et al. | Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. | 2002 | J. Biol. Chem. | pmid:12364326 |
| Rogers A et al. | Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12364420 |
| Romas E et al. | Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. | 2002 | Am. J. Pathol. | pmid:12368214 |
| Rude RK et al. | Magnesium deficiency: effect on bone and mineral metabolism in the mouse. | 2003 | Calcif. Tissue Int. | pmid:12370796 |
| David JP et al. | JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. | 2002 | J. Cell. Sci. | pmid:12376563 |
| Jones DH et al. | Role of RANKL and RANK in bone loss and arthritis. | 2002 | Ann. Rheum. Dis. | pmid:12379618 |